⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levulinic Acid SCHEMBL113572 | 0.97 | LMNA (1.00) | — | |
| Levulinic Acid SCHEMBL27931545 | 0.97 | LMNA (1.00) | — | |
| Levulinic Acid SCHEMBL20868 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL30530258 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL8063365 | 0.93 | LMNA (0.93) | — | |
| Levulinic Acid SCHEMBL21815732 | 0.93 | — | — | |
| Levulinic Acid SCHEMBL8051274 | 0.93 | LMNA (0.93) | — | |
| Levulinic Acid SCHEMBL21815633 | 0.93 | — | — | |
| Levulinic Acid SCHEMBL10791504 | 0.93 | — | — | |
| Levulinic Acid SCHEMBL7695588 | 0.93 | LMNA (0.93) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594345-B2 | Degradable hyaluronic acid hydrogels | ASCENDIS PHARMA A/S (DK) | 2026-04-07 | — | — | US | disclosed |
| US-20210338834-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | ASCENDIS PHARMA A/S (DK) | 2021-11-04 | — | — | US | disclosed |
| US-20210330798-A1 | TREATMENT OF INFECTIONS | ASCENDIS PHARMA A/S (DK) | 2021-10-28 | — | — | US | disclosed |
| EP-3856257-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | Ascendis Pharma A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| EP-3856255-A1 | TREATMENT OF INFECTIONS | Ascendis Pharma A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| CN-113164616-A | Degradable hyaluronic acid hydrogel | 阿森迪斯药物股份有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020064844-A1 | TREATMENT OF INFECTIONS | ASCENDIS PHARMA A/S (DK) | 2020-04-02 | — | — | WO | disclosed |
| WO-2020064847-A1 | DEGRADABLE HYALURONIC ACID HYDROGELS | ASCENDIS PHARMA A/S (DK) | 2020-04-02 | — | — | WO | disclosed |